Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.05. | ADDVISE GROUP AB: ADDvise announces that the conditions for early redemption of outstanding secured bonds have been fulfilled | 5 | Cision News | ||
26.05. | ADDvise Group AB (publ): ADDvise enters into facilities agreement with Nordea - reduces financial costs by approximately SEK 56 million per year | 1.434 | GlobeNewswire (Europe) | ADDvise Group AB (publ) has entered into a new secured facilities agreement with Nordea Bank Abp, filial i Sverige, with a total limit of SEK 450 million. As previously communicated, the company will... ► Artikel lesen | |
20.05. | ADDVISE GROUP AB: ADDvise announces the result of the tender offer regarding its outstanding senior secured bonds | 3 | Cision News | ||
19.05. | ADDVISE GROUP AB: ADDvise issues new SEK senior unsecured bonds | 2 | Cision News | ||
14.05. | ADDVISE GROUP AB: ADDvise intends to enter into a new facilities agreement and considers issuance of new SEK senior unsecured bonds as well as refinancing of outstanding SEK and USD senior secured bonds | 3 | Cision News | ||
12.05. | ADDvise Group AB (publ): Johan Irwe is appointed CFO, Staffan Torstensson (also CEO) assumes role as Head of the Healthcare segment, and Fredrik Mella departs | 83 | GlobeNewswire (Europe) | Since July 2024, Johan Irwe has served as interim CFO and has delivered strong results in the role. With his sharp analytical skills and dedicated leadership, Johan has created significant value for... ► Artikel lesen | |
ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
12.05. | ADDvise Group AB (publ): Report from the annual general meeting of ADDvise Group AB (publ) on 12 May 2025 | 97 | GlobeNewswire (Europe) | ADDvise Group AB (publ), reg. no. 556363-2115, has today, on 12 May 2025, held its annual general meeting at the company's premises at Grev Turegatan 30 in Stockholm. At the meeting it was resolved... ► Artikel lesen | |
09.05. | ADDvise Group AB (publ): Interim report 2025, January 1-March 31 | 92 | GlobeNewswire (Europe) | In the first quarter of 2025, net revenue increased organically with continued good profitability, which shows stable demand in medical technology and laboratory solutions. Cash flow from operating... ► Artikel lesen | |
03.05. | ADDVISE GROUP AB: Invitation to presentation of interim report January 1 - March 31, 2025 | 2 | Cision News | ||
24.04. | New equity right for trading, ADDvise Group AB | 170 | GlobeNewswire | At the request of ADDvise Group AB, equity rights will be traded on First North Growth Market as from 25 April 2025.
Security name:
ADDvise Group AB TO 1 A
Short... ► Artikel lesen | |
09.04. | Notice to the annual general meeting of ADDvise Group AB (publ) | 1 | Cision News | ||
08.04. | ADDVISE GROUP AB: ADDvise raises approximately SEK 457 million in the rights issue | 3 | Cision News | ||
08.04. | ADDVISE GROUP AB: ADDvise Group publishes annual report and sustainability report for 2024 | 4 | Cision News | ||
07.04. | ADDVISE GROUP AB: ADDvise announces preliminary outcome of the rights issue | 2 | Cision News | ||
20.03. | ADDVISE GROUP AB: ADDvise publishes prospectus in connection with a rights issue | 4 | Cision News | ||
18.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.03.2025 | 516 | Xetra Newsboard | Das Instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE EO -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.03.2025 und ex Kapitalmassnahme am 19.03.2025 The instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE... ► Artikel lesen | |
12.03. | ADDvise Group AB (publ): Report from the extra ordinary general meeting in ADDvise Group AB (publ) | 286 | GlobeNewswire (Europe) | ADDvise Group AB (publ), reg. no. 556363-2115 (the "Company"), has held an extraordinary general meeting on 12 March 2025. The general meeting resolved to amend the articles of association, approve... ► Artikel lesen | |
20.02. | ADDvise Group AB (publ): Year-end report 2024, January 1-December 31 | 145 | GlobeNewswire (Europe) | The fourth quarter of 2024 showed a turnaround in organic net revenue. In December alone, we are now back at positive organic growth of 4.8%. With new long-term financial targets, we are now taking... ► Artikel lesen | |
07.02. | Notice to extraordinary general meeting of ADDvise Group AB (publ) | 4 | Cision News | ||
07.02. | ADDVISE GROUP AB: The Board of Directors of ADDvise has resolved on a rights issue of SEK 457 million | 3 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 48,300 | +0,52 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,900 | +0,13 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
CARL ZEISS MEDITEC | 57,00 | +1,06 % | Carl Zeiss Meditec AG: Chirurgische Präzision, strategische Genauigkeit; mwb research stuft auf KAUFEN | Carl Zeiss Meditec (CZM) bleibt ein weltweit führender Anbieter in der Augenheilkunde und Mikrochirurgie, gestützt durch strukturelle Wachstumstreiber wie demografischen Wandel und die Zunahme von Sehstörungen.... ► Artikel lesen | |
MEDTRONIC | 73,67 | +0,23 % | Kaum Impulse für die Medtronic plc-Aktie (73,7742 €) | Der Kurs der dem Anteilsschein von Medtronic plc kommt kaum von der Stelle. Das Papier kostete zuletzt 85,73 US-Dollar. Die Wertschätzung der privaten und institutionellen Anlegern für die Aktie von... ► Artikel lesen | |
INTUITIVE SURGICAL | 459,00 | +0,71 % | Unglaubliche Prognose für Montag setzt Intuitive Surgical Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
UNITEDHEALTH | 263,95 | -0,02 % | Dividendenbekanntmachungen (24.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPAGNIE DE L ODET SA FR0000062234 - 4,4 EUR DOM DEVELOPMENT SA PLDMDVL00012 7 PLN 1,6374 EUR ELBIT SYSTEMS LTD IL0010811243 0... ► Artikel lesen | |
TELADOC HEALTH | 7,160 | -0,28 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) | ||
THERMO FISHER | 349,20 | +0,13 % | Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply | Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration... ► Artikel lesen | |
HIMS & HERS HEALTH | 42,410 | +0,43 % | Kein Wegovy mehr: Novo Nordisk bricht Partnerschaft: Hims & Hers-Aktie fällt ins Bodenlose! | © Foto: Christian Schultz/dpaNovo Nordisk bricht mit Hims & Hers: Beide Aktien fallen drastisch, wobei der Telemedizinanbieter aus den USA den Kürzeren zieht.Tiefschlag für die Anteilsscheine von Hims... ► Artikel lesen | |
BICO GROUP | 3,210 | -0,25 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
EUROFINS SCIENTIFIC | 60,80 | -0,23 % | Eurofins Scientific: Eurofins Announces the Success of Its New Schuldschein Issuance of €500m to Refinance its 2025 Schuldschein Loans | Regulatory News:
Eurofins Scientific (Paris:ERF) (EUFI.PA, rated Baa3 by Moody's and BBB- by Fitch), a global leader in bioanalytical testing, announces that it has successfully issued a new €500m... ► Artikel lesen | |
BECTON DICKINSON | 146,25 | +0,24 % | Becton, Dickinson and Company (BDX): A Bull Case Theory | ||
ALIGN TECHNOLOGY | 159,75 | -0,81 % | Reasons to Add Align Technology Stock to Your Portfolio Now | ||
NUGEN MEDICAL DEVICES | 0,033 | -5,75 % | NuGen Medical Devices - Lillys Geschichte: Ein Teenager aus Nordkanada… | ||
INMODE | 12,345 | +1,73 % | InMode Ltd.: InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 | YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent... ► Artikel lesen |